Basics Dyne Therapeutics, Inc. IPO Date: September 17, 2020 Sector: Healthcare Industry: Biotech Market Cap: $2.02B Activated in VL: True Average Daily Range Avg Daily Range: $0.51 | 3.26% Avg Daily Range (30 D): $0.32 | 2.87% Avg Daily Range (90 D): $0.36 | 3.19% Institutional Daily Volume Avg Daily Volume: .71M Avg Daily Volume (30 D): 2.54M Avg Daily Volume (90 D): 2.47M Trade Size Avg Trade Size (Sh.): 84 Avg Trade Size (Sh.) (30 D): 92 Avg Trade Size (Sh.) (90 D): 94 Institutional Trades Total Inst.Trades: 1,824 Avg Inst. Trade: $2.57M Avg Inst. Trade (30 D): $1.7M Avg Inst. Trade (90 D): $2.06M Avg Inst. Trade Volume: .14M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $4M Avg Closing Trade (30 D): $2.52M Avg Closing Trade (90 D): $2.86M Avg Closing Volume: 208.3K     News Aug 28, 2025 @ 5:00 PM Antisense Oligonucleotide Therapeutics Clinical Tr... Source: Delveinsight Aug 17, 2025 @ 4:42 PM INVESTOR ALERT: Pomerantz Law Firm Investigates Cl... Source: Pomerantz Llp Aug 9, 2025 @ 4:38 PM INVESTOR ALERT: Pomerantz Law Firm Investigates Cl... Source: Danielle Peyton Jul 14, 2025 @ 2:00 PM INVESTOR ALERT: Pomerantz Law Firm Investigates Cl... Source: Pomerantz Llp Jul 1, 2025 @ 1:45 AM Dyne Therapeutics Announces Pricing of $200.0 Mill... Source: Dyne Therapeutics, Inc. Financials   TTM Q2 2025 Q1 2025 Basic EPS $-3.86 $-.97 $-1.05 Diluted EPS $-3.86 $-.97 $-1.05 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -412.89M $ -110.86M $ -115.36M Operating Income / Loss $ -440.93M $ -115.79M $ -122.37M Cost of Revenue $ $ $ Net Cash Flow $ -123.08M $ 12.85M $ 36.81M PE Ratio